首頁 > 市場調查報告書 > 醫療設備

病患監測血糖監測

市場調查報告書

商品編碼

1663179

美國糖尿病監測、治療和藥物傳輸市場：市場規模、趨勢和預測（2025-2031年） - MedSuite

Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more

出版日期: 2025年02月04日 | 出版商:

iData Research Inc. | 英文 236 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

估計2024年美國糖尿病監測、治療和藥物輸送市場價值將達到 480億美元。預計該市場的年複合成長率為 7.3%，到2031年達到 790億美元。

2024年最大且成長最快的細分市場將是胰島素和 GLP-1 受體促效劑市場，佔整個市場的大部分佔有率。

追蹤劑量、計算所需胰島素和提供提醒等功能增加了對智慧胰島素筆的需求。這些設備增強了糖尿病管理，並以高昂的價格提供了極大的便利。 CGM、胰島素輸送系統和數位健康解決方案的持續改進預計將推動市場向前發展。

本報告概述了美國糖尿病監測、治療和藥物輸送市場，以及細分趨勢、市場驅動因素和限制因素以及競爭市場佔有率分析。

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Market Drivers & Limiters
Market Forecasts Until 2031 and Historical Data from 2021
Competitive Analysis & Market Shares
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
U.S. Diabetes Market Trends
Smart Reusable Insulin Pens: The demand for smart insulin pens is increasing due to their ability to track doses, calculate insulin requirements, and provide reminders. These devices enhance diabetes management and offer greater convenience despite higher pricing.
Technological Advancements: Continuous improvements in CGM, insulin delivery systems, and digital health solutions are expected to drive the market forward.

Market Share Insights

Top Competitors in the U.S. Diabetes Market (2024):

1 Novo Nordisk

* Market leader in insulin and second in insulin pens.

* Top position in ultra-long-acting & ultra-rapid-acting insulin.

* Only competitor in the rapid-acting insulin market.

* GLP-1 portfolio includes Ozempic(R), Rybelsus(R), and Xultophy(R).

2 Eli Lilly

* Second-largest competitor in the insulin market.

* Leader in premixed insulin, ultra-rapid-acting insulin, and human insulin.

* GLP-1 portfolio includes Trulicity(R), Mounjaro(R), and Zepbound(R).

3 Dexcom

* Dominates the continuous glucose monitoring (CGM) market.

* Strong sales from G6(R) (FDA approval in 2018) and G7 (FDA approval in 2023).

Market Segmentation Summary

This report suite includes all relevant market data, but individual MedCore reports are available for specific segments.

Blood Glucose Meter Market

Segmented Into: Personal & Professional

Blood Glucose Test Strip Market

Segmented Into: Personal & Professional

Lancet Market

Segmented Into: Personal & Professional

Continuous Glucose Monitoring (CGM) Market

Segmented Into: Personal & Professional

Flash Glucose Monitoring (FGM) Market

Segmented Into: Readers & Sensors

Insulin and GLP-1 Market

Insulin Types: Long-Acting, Ultra-Long-Acting, Rapid-Acting, Ultra-Rapid-Acting, Premixed, Human
GLP-1 Segments:

Diabetes Care: GLP-1 Injection, GLP-1 Oral

Obesity Care: GLP-1 Injection

Insulin Pen Market

Segmented Into: Reusable Pens & Pen Needles

Insulin Syringe Market

Segmented Into: Conventional & Safety Syringes

Insulin Pump Market

Segmented Into: Durable, Patch, and Simple Pumps

Global Research Scope

Report Attributes and Details:

Region: United States
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023

Quantitative Coverage:

Market Size, Market Shares, Market Forecasts, Growth Rates
Units Sold, Average Selling Prices

Qualitative Coverage:

COVID-19 Impact
Market Trends & Limiters
Competitive Analysis & SWOT for Leading Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Disruptive Technologies
Disease Overviews

Data Sources:

Industry Leader Interviews
Government & Regulatory Data
Hospital & Private Sector Data
Import & Export Records
iData Research Internal Database

TABLE OF CONTENT

Table of Contents

List of Figures

List of Charts

Executive Summary

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Developments

Market Trends

Market Segmentation

Key Report Updates

Version History

research methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

Disease Overview

2.1 Introduction
- 2.1.1 Types of Diabetes
- 2.1.2 Diabetes Complications
- 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
- 2.1.4 Signs and Symptoms
- 2.1.5 Diabetes Monitoring
- 2.1.6 Treatment
- 2.1.7 Drug Delivery Systems

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview

3.1 Introduction
3.2 Market Overview & Trend Analysis
3.3 Drivers and Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions

patient demographics AND INSTALLED BASE

4.1 Patient Demographics
- 4.1.1 Diagnosed Diabetes Patient Population by Type
- 4.1.2 Diagnosed Type 2 Diabetes Patient Population by Type
- 4.1.3 Diagnosed Insulin-Dependent Diabetes Patient Population by Type
4.2 Installed Base Analysis and Forecast
- 4.2.1 Personal Glucose Monitoring Installed Base by Segment
- 4.2.2 Personal CGM Installed Base by Patient Type
- 4.2.3 Insulin User Installed Base by Segment
- 4.2.4 Durable Pump Installed Base by Diabetes Type
- 4.2.5 Patch Pump Installed Base by Diabetes Type
- 4.2.6 MDI Installed Base by Segment
- 4.2.7 MDI Installed Base by Diabetes Type

Blood glucose meter Market

5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
- 5.3.1 Personal Blood Glucose Meter Market
- 5.3.2 Professional Blood Glucose Meter Market
5.4 Drivers and Limiters
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Blood Glucose test strip Market

6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
- 6.3.1 Total Blood Glucose Test Strip Market
- 6.3.2 Personal Blood Glucose Test Strip Market
  - 6.3.2.1 Medicare/Medicaid Personal Blood Glucose Test Strip Market
  - 6.3.2.2 Managed Care Personal Blood Glucose Test Strip Market
  - 6.3.2.3 Personal Cash Blood Glucose Test Strip Market
- 6.3.3 Professional Blood Glucose Test Strip Market
6.4 Drivers and Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Lancet Market

7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
- 7.3.1 Total Lancet Market
- 7.3.2 Personal Lancet Market
- 7.3.3 Professional Lancet Market
7.4 Drivers and Limiters
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

Continuous Glucose MonitorinG Market

8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
- 8.3.1 Personal Continuous Glucose Monitoring Market
  - 8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
  - 8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
  - 8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
- 8.3.2 Professional Continuous Glucose Monitoring Market
  - 8.3.2.1 Professional Continuous Glucose Monitoring System Market
  - 8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
  - 8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
8.4 Drivers and Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
- 8.5.1 Continuous Glucose Monitoring Market Installed Base Share

Flash Glucose monitoring Market

9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
- 9.3.1 Flash Glucose Monitoring Reader Market
- 9.3.2 Flash Glucose Monitoring Sensor Market
9.4 Drivers and Limiters
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Insulin and GLP-1 Market

10.1 Introduction
- 10.1.1 Insulin Types
  - 10.1.1.1 Rapid-Acting Insulin Analog
  - 10.1.1.2 Ultra-Rapid-Acting Insulin Analog
  - 10.1.1.3 Regular Human Insulin
  - 10.1.1.4 Intermediate-Acting Human Insulin
  - 10.1.1.5 Long-Acting Insulin Analog
  - 10.1.1.6 Ultra-Long-Acting Insulin Analog
  - 10.1.1.7 Premixed Insulin
10.2 Market Overview
10.3 Market Analysis and Forecast
- 10.3.1 Insulin Market
  - 10.3.1.1 Long-Acting Insulin Market
  - 10.3.1.2 Ultra-Long-Acting Insulin Market
  - 10.3.1.3 Rapid-Acting Insulin Market
  - 10.3.1.4 Ultra-Rapid-Acting Insulin Market
  - 10.3.1.5 Premixed Insulin Market
  - 10.3.1.6 Human Insulin Market
- 10.3.2 GLP-1 Market
  - 10.3.2.1 GLP-1 Diabetes Care Injection Market
  - 10.3.2.2 GLP-1 Diabetes Care Oral Market
  - 10.3.2.3 GLP-1 Obesity Care Injection Market
10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Insulin pen Market

11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
- 11.3.1 Reusable Pen Market
  - 11.3.1.1 Standard Reusable Pen Market
  - 11.3.1.2 Smart Reusable Pen Market
- 11.3.2 Pen Needle Market
  - 11.3.2.1 Conventional Pen Needle Market
  - 11.3.2.2 Safety Pen Needle Market
11.4 Drivers and Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Insulin Syringe Market

12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
- 12.3.1 Total Insulin Syringe Market
- 12.3.2 Conventional Insulin Syringe Market
- 12.3.3 Safety Insulin Syringe Market
12.4 Drivers and Limiters
- 12.4.1 Market Drivers
- 12.4.2 Market Limiters
12.5 Competitive Market Share Analysis

Insulin pump Market

13.1 Introduction
- 13.1.1 Durable Insulin Pumps
- 13.1.2 Patch Insulin Pumps
- 13.1.3 Simple Insulin Pumps
13.2 Market Overview
13.3 Market Analysis and Forecast
- 13.3.1 Durable Insulin Pump Market
  - 13.3.1.1 Durable Pump Market
  - 13.3.1.2 Infusion Set Market
  - 13.3.1.3 Pump Reservoir Market
- 13.3.2 Patch Insulin Pump Market
  - 13.3.2.1 Patch Pump System Market
  - 13.3.2.2 Insulin Pod Market
- 13.3.3 Simple Insulin Pump Market
13.4 Drivers and Limiters
- 13.4.1 Market Drivers
- 13.4.2 Market Limiters
13.5 Competitive Market Share Analysis
- 13.5.1 Durable Insulin Pump Market
- 13.5.2 Insulin Pump Market Installed Base Share

Abbreviations

簡介目錄圖表

LIST OF CHARTS

Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2024 - 2031
Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2024 & 2031
Chart 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 - 2031
Chart 3-2: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2024
Chart 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 - 2031
Chart 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 - 2031
Chart 5-2: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
Chart 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 - 2031
Chart 6-2: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
Chart 7-1: Lancet Market by Segment, U.S., 2021 - 2031
Chart 7-2: Leading Competitors, Lancet Market, U.S., 2024
Chart 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031
Chart 8-2: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
Chart 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 - 2031
Chart 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 - 2031
Chart 10-2: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
Chart 11-1: Insulin Pen Market by Segment, U.S., 2021 - 2031
Chart 11-2: Leading Competitors, Insulin Pen Market, U.S., 2024
Chart 12-1: Insulin Syringe Market by Segment, U.S., 2021 - 2031
Chart 12-2: Leading Competitors, Insulin Syringe Market, U.S., 2024
Chart 13-1: Insulin Pump Market by Segment, U.S., 2021 - 2031
Chart 13-2: Leading Competitors, Insulin Pump Market, U.S., 2024

LIST OF FIGURES

Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (1 of 2)
Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (2 of 2)
Figure 1-3: Companies Researched in this Report, U.S., 2024 (1 of 2)
Figure 1-4: Companies Researched in this Report, U.S., 2024 (2 of 2)
Figure 1-5: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 - 2024 (1 of 2)
Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 - 2024 (2 of 2)
Figure 1-7: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (1 of 2)
Figure 1-8: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (2 of 2)
Figure 1-9: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (1 of 2)
Figure 1-10: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (2 of 2)
Figure 1-11: Patient Demographics and Installed Base Segmentation
Figure 1-12: Key Report Updates
Figure 1-13: Version History
Figure 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
Figure 3-2: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
Figure 3-3: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (1 of 2)
Figure 3-4: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (2 of 2)
Figure 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 - 2031
Figure 4-2: Diagnosed Type 2 Diabetes Patient Population by Type, U.S., 2021 - 2031
Figure 4-3: Diagnosed Insulin-Dependent Diabetes Patient Population by Type, U.S., 2021 - 2031
Figure 4-4: Glucose Monitoring Installed Base by Segment, U.S., 2021 - 2031
Figure 4-5: Personal CGM Installed Base by Patient Type, U.S., 2021 - 2031
Figure 4-6: Insulin User Installed Base by Segment, U.S., 2021 - 2031
Figure 4-7: Durable Pump Installed Base by Diabetes Type, U.S., 2021 - 2031
Figure 4-8: Patch Pump Installed Base by Diabetes Type, U.S., 2021 - 2031
Figure 4-9: MDI Installed Base by Segment, U.S., 2021 - 2031
Figure 4-10: MDI Installed Base by Diabetes Type, U.S., 2021 - 2031
Figure 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 5-2: Personal Blood Glucose Meter Market, U.S., 2021 - 2031
Figure 5-3: Professional Blood Glucose Meter Market, U.S., 2021 - 2031
Figure 5-4: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
Figure 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 6-2: Total Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-3: Personal Blood Glucose Test Strip Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 6-4: Total Personal Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-5: Medicare/Medicaid Personal Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-6: Managed Care Personal Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-7: Personal Cash Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-8: Professional Blood Glucose Test Strip Market, U.S., 2021 - 2031
Figure 6-9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
Figure 7-1: Lancet Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 7-2: Total Lancet Market, U.S., 2021 - 2031
Figure 7-3: Personal Lancet Market, U.S., 2021 - 2031
Figure 7-4: Professional Lancet Market, U.S., 2021 - 2031
Figure 7-5: Leading Competitors, Lancet Market, U.S., 2024
Figure 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-2: Personal Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2021 - 2031
Figure 8-4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2021 - 2031
Figure 8-5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2021 - 2031
Figure 8-6: Professional Continuous Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 8-7: Professional Continuous Glucose Monitoring System Market, U.S., 2021 - 2031
Figure 8-8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2021 - 2031
Figure 8-9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2021 - 2031
Figure 8-10: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
Figure 8-11: Leading Competitors, Continuous Glucose Monitoring Market Installed Base Share, U.S., 2024
Figure 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 9-2: Flash Glucose Monitoring Reader Market, U.S., 2021 - 2031
Figure 9-3: Flash Glucose Monitoring Sensor Market, U.S., 2021 - 2031
Figure 9-4: Leading Competitors, Flash Glucose Monitoring Market, U.S., 2024
Figure 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-2: Insulin Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-3: Total Insulin Market, U.S., 2021 - 2031
Figure 10-4: Long-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-5: Ultra-Long-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-6: Rapid-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-7: Ultra-Rapid-Acting Insulin Market, U.S., 2021 - 2031
Figure 10-8: Premixed Insulin Market, U.S., 2021 - 2031
Figure 10-9: Human Insulin Market, U.S., 2021 - 2031
Figure 10-10: GLP-1 Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 10-11: Total GLP-1 Market, U.S., 2021 - 2031
Figure 10-12: GLP-1 Diabetes Care Injection Market, U.S., 2021 - 2031
Figure 10-13: GLP-1 Diabetes Care Oral Market, U.S., 2021 - 2031
Figure 10-14: GLP-1 Obesity Care Injection Market, U.S., 2021 - 2031
Figure 10-15: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
Figure 10-16: Leading Competitors, Insulin Market, U.S., 2024
Figure 10-17: Leading Competitors, GLP-1 Market, U.S., 2024
Figure 11-1: Insulin Pen Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 11-2: Reusable Pen Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 11-3: Total Reusable Pen Market, U.S., 2021 - 2031
Figure 11-4: Standard Reusable Pen Market, U.S., 2021 - 2031
Figure 11-5: Smart Reusable Pen Market, U.S., 2021 - 2031
Figure 11-6: Pen Needle Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 11-7: Total Pen Needle Market, U.S., 2021 - 2031
Figure 11-8: Conventional Pen Needle Market, U.S., 2021 - 2031
Figure 11-9: Safety Pen Needle Market, U.S., 2021 - 2031
Figure 11-10: Leading Competitors, Insulin Pen Market, U.S., 2024
Figure 12-1: Insulin Syringe Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 12-2: Total Insulin Syringe Market, U.S., 2021 - 2031
Figure 12-3: Total Conventional Insulin Syringe Market, U.S., 2021 - 2031
Figure 12-4: Safety Insulin Syringe Market, U.S., 2021 - 2031
Figure 12-5: Leading Competitors, Insulin Syringe Market, U.S., 2024
Figure 13-1: Insulin Pump Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 13-2: Durable Insulin Pump Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 13-3: Durable Pump Market, U.S., 2021 - 2031
Figure 13-4: Infusion Set Market, U.S., 2021 - 2031
Figure 13-5: Pump Reservoir Market, U.S., 2021 - 2031
Figure 13-6: Patch Insulin Pump Market by Segment, U.S., 2021 - 2031 (US$M)
Figure 13-7: Patch Pump System Market, U.S., 2021 - 2031
Figure 13-8: Insulin Pod Market, U.S., 2021 - 2031
Figure 13-9: Simple Insulin Pump Market, U.S., 2021 - 2031
Figure 13-10: Leading Competitors, Insulin Pump Market, U.S., 2024
Figure 13-11: Leading Competitors, Durable Insulin Pump Market, U.S., 2024
Figure 13-12: Leading Competitors, Insulin Pump Market Installed Base Share, U.S., 2024